BNTX
BioNTech SENASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$23.30B
P/E Ratio
—
EPS
$-5.90
Beta
1.37
52W High
$124.00
52W Low
$79.52
50-Day MA
$94.57
200-Day MA
$101.22
Dividend Yield
—
Profit Margin
-44.60%
Forward P/E
7.04
PEG Ratio
0.05
About BioNTech SE
BioNTech SE, a biotechnology company, develops and markets immunotherapies for cancer and other infectious diseases. The company is headquartered in Mainz, Germany.
Fundamentals
| Revenue (TTM) | $2.81B |
| Gross Profit (TTM) | $2.21B |
| EBITDA | $-1.19B |
| Operating Margin | -577.00% |
| Return on Equity | -6.66% |
| Return on Assets | -4.18% |
| Revenue/Share (TTM) | $11.45 |
| Book Value | $85.90 |
| Price-to-Book | 1.03 |
| Price-to-Sales (TTM) | 8.31 |
| EV/Revenue | 2.039 |
| EV/EBITDA | 32.70 |
| Quarterly Earnings Growth (YoY) | -43.20% |
| Quarterly Revenue Growth (YoY) | -35.40% |
| Shares Outstanding | $252.88M |
| Float | $110.05M |
| % Insiders | 57.42% |
| % Institutions | 20.09% |
Historical Volatility
HV 10-Day
25.13%
HV 20-Day
34.35%
HV 30-Day
38.00%
HV 60-Day
58.12%
HV Rank
40.9%
Volatility is currently contracting
Analyst Ratings
Consensus ($123.05 target)
1
Strong Buy13
Buy3
Hold1
Strong SellMore HEALTHCARE Stocks
Data last updated: 5/25/2026